Tight Junction
The tight junction (zonula occludens) is a multiprotein intercellular adhesion complex that encircles the apical pole of polarized vertebrate epithelial and endothelial cells, sealing the paracellular space between adjacent plasma membranes.
The tight junction (zonula occludens) is a multiprotein intercellular adhesion complex that encircles the apical pole of polarized vertebrate epithelial and endothelial cells, sealing the paracellular space between adjacent plasma membranes. In freeze-fracture transmission electron microscopy, tight junctions appear as an anastomosing network of intramembranous particle strands that bring neighboring outer membrane leaflets into close apposition, obliterating the intercellular cleft at discrete kissing points. Tight junctions fulfill two coupled physiological functions: a gate (barrier) function, which regulates the paracellular diffusion of water, ions, and solutes across tissue sheets according to charge and molecular radius, and a fence function, which restricts the lateral diffusion of lipids and integral membrane proteins between the apical and basolateral plasma membrane domains to preserve epithelial cell polarity.
Unlike invertebrates—which seal their epithelia primarily through subapical septate junctions—chordates and tunicates construct canonical tight junctions built around four-transmembrane-helix claudin proteins, TAMPs (Tight Junction-Associated Marvel Proteins) such as occludin and tricellulin, and single-pass immunoglobulin superfamily proteins (JAMs). On the cytoplasmic face, these transmembrane strands are tethered to the cortical perijunctional actomyosin ring by Zonula Occludens (ZO-1, ZO-2, and ZO-3) scaffolding proteins via liquid–liquid phase separation (LLPS) and multi-domain PDZ–SH3–GUK interactions.
Molecular Architecture of the Junctional Complex
In polarized vertebrate simple epithelia (such as the intestinal mucosa and renal tubular epithelium), the intercellular apical junctional complex is organized into a conserved apico-basal tripartite hierarchy:
1. Claudins: The Polymeric Backbone of Paracellular Strands
First identified by Mikio Furuse and Shoichiro Tsukita in 1998, claudins constitute a multigene family of 26–27 tetraspan integral membrane proteins (20–34 kDa) in mammals. Each claudin monomer contains four transmembrane α-helices (TM1–TM4), short intracellular N- and C-termini, two extracellular loops (ECL1 and ECL2), and a C-terminal PDZ-binding motif (typically –YV) that binds the PDZ1 domain of ZO-1, ZO-2, and ZO-3:
- Extracellular Loop 1 (ECL1, ~50–55 amino acids): Folds into a five-stranded antiparallel β-sheet stabilized by a conserved disulfide bridge (C–X8–10–C motif) within a –GLW– signature sequence. Charged amino acid residues lining ECL1 project into the intercellular space to determine the electrostatic charge selectivity (cation vs. anion preference) of paracellular pores.
- Extracellular Loop 2 (ECL2, ~25 amino acids): Forms a helix-turn-helix structure that mediates trans-interactions across the intercellular gap with claudins on the opposing cell membrane, driving the polymerization of antiparallel double-row claudin strands.
2. TAMPs (Occludin, Tricellulin, MarvelD3) and JAMs
- Occludin (OCLN): A ~65 kDa tetraspan protein containing a four-transmembrane MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain and a coiled-coil C-terminal domain that binds ZO-1. While Ocln−/− knockout mice still assemble morphologically recognizable claudin strands, occludin regulates macromolecular leak pathway flux, epithelial apoptosis sensitivity, and cochlear hair-cell survival.
- Tricellulin (MARVELD2) and Angulins (ILDR1, ILDR2, LSR): At tricellular tight junctions (tTJs)—where three polygonal epithelial cells meet at a vertex—the bicellular tight junction strands turn basolaterally to form a ~1 μm deep central tube (~10 nm diameter). Angulin-1 (LSR) and Angulin-2 (ILDR1) recruit tricellulin to seal this tricellular vertex against paracellular macromolecule leakage and maintain inner-ear endolymphatic potential.
- Junctional Adhesion Molecules (JAM-A, JAM-B, JAM-C): Single-pass transmembrane immunoglobulin superfamily (IgSF) proteins with two extracellular Ig-like domains (V-type and C2-type) that regulate leukocyte transendothelial diapedesis and recruit the Par3–Par6–aPKC polarity complex during junction assembly.
3. Zonula Occludens (ZO) Scaffolding and Phase Separation
The cytoplasmic plaque is organized by ZO-1 (TJP1), ZO-2 (TJP2), and ZO-3 (TJP3), members of the membrane-associated guanylate kinase (MAGUK) superfamily. Each ZO protein contains three N-terminal PDZ domains (PDZ1 binds claudin C-termini; PDZ2 mediates ZO dimerization and connexin-43 binding; PDZ3 binds JAM-A), an SH3–hinge–GUK module that binds occludin and α-catenin, and a C-terminal actin-binding region (ABR). Modern biophysical studies show that multivalent interactions within the intrinsically disordered PSG–U6 regions of ZO-1 drive liquid–liquid phase separation (LLPS) at the apical membrane border, concentrating claudins above their nucleation threshold so they polymerize into continuous tight-junction belts.
Biophysical Mechanisms: Pore Pathway vs. Leak Pathway
Paracellular transport across tight junctions occurs through two biophysically distinct routes that determine the transepithelial electrical resistance (TEER):
| Biophysical Property | High-Capacity Pore Pathway | Low-Capacity Leak Pathway |
|---|---|---|
| Molecular Radius Cutoff | ≤ 4.0–4.5 Å (hydrated ions and water) | ~10–60 Å (uncharged sugars, peptides, small proteins) |
| Charge Selectivity | Strongly charge-selective (cation- or anion-selective) | Non-charge-selective (size-restricted only) |
| Structural Determinants | Channel-forming claudins (Claudin-2, -10a, -10b, -15, -16/-19) | Dynamic strand breaks, occludin, tricellulin, and MLCK-driven actomyosin tension |
| Primary Regulators | Transcription and endocytosis of pore vs. barrier claudins; IL-13 / IL-22 | Myosin Light Chain Kinase (MLCK) phosphorylation of MLC20; TNF-α / IFN-γ |
Barrier-Forming vs. Pore-Forming Claudins
The specific claudin isoform repertoire expressed by an epithelium sets its TEER across three orders of magnitude—from "leaky" proximal renal tubules and small intestine (TEER ≈ 10–100 Ω·cm2) to "tight" urinary bladder urothelium and the blood–brain barrier (TEER ≈ 1,500–10,000 Ω·cm2):
- Barrier-Forming Claudins (CLDN1, CLDN3, CLDN4, CLDN5, CLDN11, CLDN14, CLDN18, CLDN19): Seal the paracellular cleft and elevate TEER. Claudin-1 is indispensable for the epidermal stratum granulosum water barrier; Claudin-5 is the dominant endothelial tight junction protein sealing the blood–brain barrier against molecules >400–800 Da; Claudin-11 seals CNS myelin intralamellar tight junctions and Sertoli-cell blood–testis barriers.
- Cation-Pore Claudins (CLDN2, CLDN10b, CLDN15, CLDN16/19): Contain negatively charged aspartate or glutamate residues in ECL1 (such as Asp65 in Claudin-2) that coordinate and dehydrate cations. Claudin-2 and Claudin-15 form paracellular Na+ and water channels in the intestinal crypts and renal proximal convoluted tubule, driving paracellular Na+ recycling required for Na+-glucose (SGLT1) cotransport. In the thick ascending limb of the loop of Henle, heteromeric Claudin-16 / Claudin-19 complexes form the paracellular pore for Mg2+ and Ca2+ reabsorption.
- Anion-Pore Claudins (CLDN10a, CLDN17): Contain positively charged basic residues (arginine/lysine) in ECL1 that conduct Cl− and HCO3− across the renal proximal tubule.
Pathophysiology, Microbial Toxins, and Clinical Pharmacology
Defects in tight junction genes or inflammatory disruption of the paracellular barrier underlie a wide spectrum of hereditary syndromes and infectious diseases:
- Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis (FHHNC): Autosomal recessive loss-of-function mutations in CLDN16 (paracellin-1) or CLDN19 abolish paracellular Mg2+ and Ca2+ reabsorption in the thick ascending limb of Henle, causing urinary magnesium wasting, medullary nephrocalcinosis, and progressive renal failure (accompanied by pronounced ocular macular coloboma in CLDN19 mutations).
- NISCH Syndrome and Non-Syndromic Deafness (DFNB29 / DFNB49): Null mutations in CLDN1 cause Neonatal Ichthyosis–Sclerosing Cholangitis (NISCH) syndrome due to epidermal and biliary ductular barrier collapse. Mutations in CLDN14 (DFNB29) or MARVELD2 (tricellulin, DFNB49) allow K+-rich endolymph (+80 to +100 mV endocochlear potential) to leak across the reticular lamina into the perilymph, intoxicating outer hair cells and causing congenital sensorineural deafness.
- Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis): Mucosal TH1/TH2 cytokines remodel the intestinal tight junction via two pathways: TNF-α activates long-isoform myosin light chain kinase (MLCK1), which phosphorylates myosin regulatory light chain (MLC20) at Ser19, contracting the perijunctional actomyosin ring, triggering caveolar endocytosis of occludin, and opening the leak pathway; simultaneously, IL-13 activates STAT6 to upregulate pore-forming Claudin-2, increasing pore pathway Na+ and water efflux into the gut lumen (leak-flux diarrhea).
- Microbial Pathogens and Tight-Junction Receptors:
- Clostridium perfringens Enterotoxin (CPE): A 35 kDa pore-forming toxin whose C-terminal receptor-binding domain (cCPE) binds with nanomolar affinity to the ECL2 loop of Claudin-3 and Claudin-4, stripping claudins from the tight junction and forming hexameric β-barrel plasma membrane pores that trigger Ca2+-mediated enterocyte lysis.
- Hepatitis C Virus (HCV): Requires both Claudin-1 (ECL1) and Occludin (ECL2) as mandatory post-binding coreceptors—after initial attachment to SR-BI and CD81—to enter human hepatocytes at the canalicular tight junction margin.
- Oncology Biotech (Zolbetuximab): In healthy gastric mucosa, Claudin-18.2 is buried within tight junction strands and inaccessible to circulating antibodies; during malignant transformation into gastric or gastroesophageal junction adenocarcinoma, loss of epithelial polarity exposes Claudin-18.2 on the tumor cell surface, enabling targeted antibody-dependent cellular cytotoxicity by the monoclonal antibody zolbetuximab.
References
- Furuse, M., Fujita, K., Hiiragi, T., Fujimoto, K., & Tsukita, S. (1998). Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. Journal of Cell Biology, 141(7), 1539–1550. Google Scholar
- Zihni, C., Mills, C., Matter, K., & Balda, M. S. (2016). Tight junctions: from simple barriers to multifunctional molecular gates. Nature Reviews Molecular Cell Biology, 17(9), 564–580. Google Scholar
- Beutel, O., Maraspini, R., Pombo-García, K., Martin-Lemaitre, C., & Honigmann, A. (2019). Phase separation of zonula occludens proteins drives formation of tight junctions. Cell, 179(4), 923–936. Google Scholar
- Horowitz, A., Chanez-Paredes, S. D., Haest, X., & Turner, J. R. (2023). Paracellular permeability and tight junction regulation in gut health and disease. Nature Reviews Gastroenterology & Hepatology, 20(7), 417–432. Google Scholar